2.16
7.46%
+0.15
Handel nachbörslich:
2.16
Schlusskurs vom Vortag:
$2.01
Offen:
$2.169
24-Stunden-Volumen:
3,103
Marktkapitalisierung:
$24.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.15M
KGV:
-10.44
EPS:
-0.2069
Netto-Cashflow:
$-2.23M
1W Leistung:
+4.49%
1M Leistung:
+2.37%
6M Leistung:
-41.46%
1J Leistung:
-20.88%
CytoMed Therapeutics Ltd Stock (GDTC) Company Profile
Firmenname
CytoMed Therapeutics Ltd
Sektor
Branche
Telefon
65 6250 7738
Adresse
1 Commonwealth Lane, No. 08-22, Singapore
CytoMed Therapeutics Ltd Aktie (GDTC) Neueste Nachrichten
CytoMed Therapeutics : Annual Shareholders Meeting - Form 6-K - Marketscreener.com
Marketscreener.com
Wall Street Breakfast: The Week Ahead
Seeking Alpha
CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General ... - Yahoo Finance
Yahoo Finance
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
GlobeNewswire Inc.
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
GlobeNewswire Inc.
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to ... - GlobeNewswire
GlobeNewswire
Finanzdaten der CytoMed Therapeutics Ltd-Aktie (GDTC)
CytoMed Therapeutics Ltd (GDTC) Nettogewinn 2024
GDTC betrug am 2023-06-30 der Nettogewinn der letzten 12 Monate -3.15 Millionen US-Dollar.
CytoMed Therapeutics Ltd (GDTC) Free Cashflow 2024
GDTC verzeichnete einen Free Cashflow der letzten 12 Monate von -2.23 Millionen US-Dollar für das Quartal bis zum 2023-06-30.
CytoMed Therapeutics Ltd (GDTC) Gewinn je Aktie 2024
Der Gewinn je Aktie (EPS) von GDTC für die letzten 12 Monate betrug -0.3052 US-Dollar für das Quartal, das am 2023-06-30 endete.
Kapitalisierung:
|
Volumen (24h):